Keith Dewedoff

Keith brings more than 20 years of experience in the life science industry, ranging from biotech venture-backed start-ups to commercial publicly traded companies. Prior to joining Spy, Keith also serves as a CFO and Advisor for Danforth Advisors, an advisory firm focused on providing financial strategy to life science organizations. He previously served as CFO of Ceptur Therapeutics and more than 10 other privately held and public companies at various life cycle stages; managing finance, accounting, corporate & business development, and other corporate operational functions. Prior to Danforth, Keith was CFO of Kaizen Bioscience where he is still active on the board as Chair and also serves as a venture partner at an early-stage incubator focused on infectious diseases.

Keith earned a Bachelor of Science in Economics from Northeastern University and studied graduate work at Oxford University.